Abstract
ACE I/D and AT1R 1166A/C polymorphisms are considered to comprise individual risk factors for the development of coronary disease. We sought to demonstrate that the ACE I/D and AT1R 1166A/C polymorphisms affect coronary artery stenosis in patients with Kawasaki disease (KD). We examined 147 healthy controls and 281 Japanese children with KD. The patients were further divided into group N (n = 246, no ischemia) and group I (n = 35, severe coronary artery stenosis with myocardial ischemia), and we studied the genotype of ACE I/D and AT1R 1166A/C polymorphisms. We also examined ACE activity in patients with acute KD. We did not detect any prevalent genotypes of the ACE and AT1R polymorphisms between controls and KD patients. However, the prevalence of the D allele in the ACE polymorphism and of the C allele in the AT1R polymorphism tended to be higher in group I than in group N (odds ratios, 2.00 and 2.32, respectively). In addition, the presence of the D and/or C alleles significantly increased the relative risk of developing myocardial ischemia (odds ratio, 2.71; p = 0.038). During the convalescent phase of KD, ACE activity was increased despite significant attenuation during the acute phase. These results suggested that the renin-angiotensin system is associated with the formation of severe coronary artery stenosis and myocardial ischemia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ACE:
-
angiotensin converting enzyme
- AgII:
-
angiotensin II
- AT1R:
-
angiotensin II type 1 receptor
- CA:
-
coronary artery
- CAD:
-
coronary artery disease
- IVIG:
-
intravenous Ig therapy
- KD:
-
Kawasaki disease
- RAS:
-
renin-angiotensin system
References
Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, Kawasaki T 2001 Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 107: E33
Matsubara T, Furukawa S, Yabuta K 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56: 29–36
Gupta M, Noel GJ, Schaefer M, Friedman D, Bussel J, Johann-Liang R 2001 Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 21: 193–199
Intengan HD, Schiffrin EL 2001 Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38: 581–587
Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D, Heraud V 1994 Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 89: 952–954
Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K 1995 Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest 96: 2975–2979
Myerson SG, Montgomery HE, Whittingham M, Jubb M, World MJ, Humphries SE, Pennell DJ 2001 left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan. Circulation 103: 226–230
Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K 1994 Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90: 2199–2202
Ferrari M, Mudra H, Grip L, Voudris V, Schachinger V, de Jaegere P, Rieber J, Hausmann D, Rothman M, Koschyk DH, Figulla HR OPTICUS ACE Substudy 2002 Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation. Cardiology 97: 29–36
Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F 1992 Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641–644
Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TI, Jensen G, Tybjaerg-Hansen A 1997 ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 95: 2358–2367
Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, Darmon O, Guize L, Guermonprez JL, Diebold B, Ducimetiere P 1997 Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 99: 66–73
Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH 1995 A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706–711
Gardemann A, Fink M, Stricker J, Nguyen QD, Humme J, Katz N, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W 1998 ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 139: 153–159
Hamon M, Amant C, Bauters C, Richard F, Helbecque N, Passard F, McFadden EP, Lablanche JM, Bertrand ME, Amouyel P 1998 Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol 81: 79–81
Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, soubrier F, Cambien F 1994 Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344: 910–913
Pfeffer MA, McMurray JJV, Velazquez EJ, Rouleau J-L, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Valsartan in Acute Myocardial Infarction Trial Investigators 2003 Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349: 1893–1906
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342: 145–153
Amano S, Hazama F, Hamashima Y 1979 Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 43: 633–643
Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C 2000 Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J 41: 245–256
Nickenig G, Harrison DG 2002 The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation 105: 393–396
Nickenig G, Harrison DG 2002 The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part II: AT(1) receptor regulation. Circulation 105: 530–536
Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaka A, Sato S, Uchiyama M 1997 High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 156: 266–268
Falcini F, Generini S, Pignone A, Leoncini G, Cimaz R, Partsch G, Matucci-Cerinic M 1999 Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?. Endothelium 6: 209–215
Kuramochi Y, Ohkubo T, Takechi N, Ogawa S 2001 Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki disease as an early management strategy. Pediatr Cardiol 22: 183–187
Ogawa S, Fukazawa R, Ohkubo T, Zhang J, Takechi N, Kuramochi Y, Hino Y, Jimbo O, Katsube Y, Kamisago M, Genma Y, Yamamoto M 1997 Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 96: 3384–3389
Kasahara Y, Ashihara Y 1981 Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 27: 1922–1925
Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Camilla T, Vado A, Benetton G, Uslenghi E, Piazza A 1998 Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 97: 147–154
Koch W, Mehilli J, von Beckerath N, Bottiger C, Schomig A, Kastrati A 2003 Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. J Am Coll Cardiol 41: 1957–1961
Patten RD, Aronovitz MJ, Einstein M, Lambert M, Pandian NG, Mendelsohn ME, Konstam MA 2003 Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin Sci (Lond) 104: 109–118
Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K 1996 Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93: 1630–1633
Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, Miki T, Higaki J, Ogihara T 1998 Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 11: 316–321
Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, Benetos A 2001 Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 19: 407–413
Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, Poirier O, Soubrier F, Safar M, Cambien F 1995 Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 26: 44–47
Wang WY, Zee RY, Morris BJ 1997 Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 51: 31–34
Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F 1994 Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24: 63–69
Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, Escudero X, Lablanche JM, Amouyel P, Bertrand ME 1997 The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 29: 486–490
Prasad A, Narayanan S, Waclawiw MA, Epstein N, Quyyumi AA 2000 The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity. J Am Coll Cardiol 36: 1579–1586
Harada K, Komuro I, Sugaya T, Murakami K, Yazaki Y 1999 Vascular injury causes neointimal formation in angiotensin II type 1a receptor knockout mice. Circ Res 84: 179–185
Acknowledgements
The authors thank Mrs. Katsuko Honjo for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 12670787), Tokyo, Japan, and by Bayer Yakuhin Ltd., Tokyo, Japan.
Rights and permissions
About this article
Cite this article
Fukazawa, R., Sonobe, T., Hamamoto, K. et al. Possible Synergic Effect of Angiotensin-I Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-II Type-1 Receptor 1166A/C Gene Polymorphism on Ischemic Heart Disease in Patients with Kawasaki Disease. Pediatr Res 56, 597–601 (2004). https://doi.org/10.1203/01.PDR.0000139426.16381.C8
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000139426.16381.C8
This article is cited by
-
A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children
Human Cell (2022)
-
Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients
BMC Research Notes (2017)
-
Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population
Tumor Biology (2013)
-
Genetic polymorphisms in Kawasaki disease
Acta Pharmacologica Sinica (2011)
-
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children
Journal of Human Genetics (2011)
